original ) (raw )Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia in the Combination of Avodart and Tamsulosin (CombAT) trial
Ramiro Castro , Jack Barkin , Andrea Tubaro , Steven Kaplan
Journal of Men's Health, 2009
View PDFchevron_right
The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study
Jack Barkin , Claus Roehrborn
European Urology, 2010
View PDFchevron_right
The effects of dutasteride, tamsulosin, and the combination on storage and voiding symptoms in men with moderate-to-severe BPH: 4-year results from the CombAT study
Jack Barkin
Journal of Men's Health, 2010
View PDFchevron_right
Dutasteride significantly improves quality of life measures in patients with enlarged prostate
Libby Black
Prostate Cancer and Prostatic Diseases, 2008
View PDFchevron_right
Effect of Dutasteride on Prostate Biopsy Rates and the Diagnosis of Prostate Cancer in Men with Lower Urinary Tract Symptoms and Enlarged Prostates in the Combination of Avodart and Tamsulosin Trial
Ramiro Castro
European Urology, 2011
View PDFchevron_right
The effects of combination therapy with dutasteride plus tamsulosin on clinical outcomes in men with symptomatic BPH: 4-year post hoc analysis of European men in the CombAT study
Venancio Chantada
Prostate Cancer and Prostatic Diseases, 2011
View PDFchevron_right
Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate
Ronaldo Damião
Clinical Interventions in Aging, 2009
View PDFchevron_right
The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the Combination of Avodart and Tamsulosin study
Timothy D Wilson
Prostate Cancer and Prostatic Diseases, 2009
View PDFchevron_right
Experience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasia
Bilal Chughtai
Therapeutic advances in urology, 2012
View PDFchevron_right
356 Inhibition of Prostate Cancer Progression by Dutasteride and the Impact on Anxiety, Quality of Life, and Urinary Symptoms in Men Undergoing Active Surveillance: Redeem Study Results
Scott Lucia
Journal of Urology, 2011
View PDFchevron_right
Review of dutasteride/tamsulosin fixed-dose combination for the treatment of benign prostatic hyperplasia: efficacy, safety, and patient acceptability
Jack Barkin
Patient Preference and Adherence, 2011
View PDFchevron_right
Correlation of the Impact of Tamsulosin/Dutasteride Combination Therapy on Erectile Dysfunction (Ed) in Benign Prostatic Hyperplasia (BPH) in Pku Muhammadiyah Gombong Hospital, Kebumen
Akhmad Miftahudin Fazri
Indonesian Journal of Urology
View PDFchevron_right
Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study
Girish Kulkarni
BMJ (Clinical research ed.), 2013
View PDFchevron_right
Cost-effectiveness of dutasteride-tamsulosin combination therapy for the treatment of symptomatic benign prostatic hyperplasia: A Canadian model based on the CombAT trial
John Posnett
Canadian Urological Association Journal, 2012
View PDFchevron_right
Effect of Dutasteride on the Risk of Prostate Cancer
Claudio Teloken
New England Journal of Medicine, 2010
View PDFchevron_right
The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate—a long-term follow-up comparison and quality of life analysis
Siebren Dijkstra
SpringerPlus, 2016
View PDFchevron_right
Efficacy and Safety of Long-Term Treatment with the Dual 5α-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic Hyperplasia
Mario Reis
European Urology, 2004
View PDFchevron_right
Finasteride to Evaluate the Efficacy of Dutasteride in the Management of Patients with Lower Urinary Tract Symptoms and Enlarged Prostate
Rajendra nerli
Archives of Andrology, 2007
View PDFchevron_right
The Effectiveness and Safety of Dutasteride in the Treatment of Benign Prostatic Hyperplasia
Ismail Raji
View PDFchevron_right
Cost-effectiveness of single-dose tamsulosin and dutasteride combination therapy compared with tamsulosin monotherapy in patients with benign prostatic hyperplasia in the UK
John Posnett
BJUI, 2013
View PDFchevron_right
Impact of early vs. delayed initiation of dutasteride/tamsulosin combination therapy on the risk of acute urinary retention or BPH-related surgery in LUTS/BPH patients with moderate-to-severe symptoms at risk of disease progression
dr chandrashekhar chavan chavan
World Journal of Urology, 2020
View PDFchevron_right
Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5α-reductase inhibitor
Michael O'Leary
BJU International, 2003
View PDFchevron_right
Comparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia: a randomized controlled trial
HIDEKI ORIGASA
BJU International, 2005
View PDFchevron_right
Tamsulosin 0 . 4 mg in the Treatment of Symptomatic BPH : Assessment of Response in African Men
Shuaibu Ibrahim
2016
View PDFchevron_right
Short-term effect of tamsulosin and finasteride monotherapy and their combination on nigerian men with benign prostatic hyperplasia
Tijani K. H.
Nigerian Journal of Surgery
View PDFchevron_right